https://www.selleckchem.com/pr....oducts/carfilzomib-p
85 (95%CI 1.8 to 13.06, p less then .01), area under curve (AUC) 0.65) and neurological outcome (fully-adjusted odds ratio 3.96 (95%CI 1.47 to 10.66, p less then .01), AUC 0.63). CONCLUSIONS ACs are interesting surrogate biomarkers that are associated with mortality and poor neurological outcome in patients after OHCA and may help to improve the understanding of pathophysiological mechanisms and risk stratification. Gastropod shells may present large spines and sharp shapes that vary according to environmental, taxonomic, and
Like
Comment
Share
